Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

5.21
+0.10001.96%
Pre-market: 5.210.0005+0.01%05:31 EDT
Volume:713.74K
Turnover:3.69M
Market Cap:163.02M
PE:-1.26
High:5.28
Open:5.06
Low:5.01
Close:5.11
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.32
T/O Rate:3.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.74
PE(LYR):-1.83

Loading ...

ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year

TIPRANKS
·
Aug 17

Valerio Therapeutics Nears Signing of €30 Million Etherna Acquisition

TIPRANKS
·
Aug 17

HLS Therapeutics upgraded to Strong Buy from Outperform at Raymond James

TIPRANKS
·
Aug 17

Press Release: Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

Dow Jones
·
Aug 17

Chimeric Therapeutics Halts Trading Ahead of CDH17 Trial Results

TIPRANKS
·
Aug 17

Quince Therapeutics participates in a conference call with Cantor Fitzgerald

TIPRANKS
·
Aug 17

Damora Therapeutics (DMRA) Starts CLARITY 101 Trial With Valuation Still In Focus

Simply Wall St.
·
Aug 17

Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)

TIPRANKS
·
Aug 16

Revive Therapeutics Grants 15.5 Million Stock Options to Key Team Members

TIPRANKS
·
Aug 15

Protagenic Therapeutics Delays Quarterly SEC Filing

TIPRANKS
·
Aug 15

Neural Therapeutics Wins CSE Nod for Hanf.com Deal and Name Change

TIPRANKS
·
Aug 15

Press Release: BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 15

Stifel Nicolaus Reaffirms Their Hold Rating on HLS Therapeutics Inc (HLS)

TIPRANKS
·
Aug 15

CAMP4 Therapeutics Price Target Raised to $15.00/Share from $12.00 by Piper Sandler

Dow Jones
·
Aug 15

ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says

MT Newswires Live
·
Aug 14

Skye Bioscience to Merge with Redx, Form Fibrx Therapeutics

TIPRANKS
·
Aug 14

Outlook Therapeutics Announces $55 Million Equity Offering

TIPRANKS
·
Aug 14

Silexion Therapeutics Q2 EPS $(5.17) Misses $(2.12) Estimate

Benzinga Earnings
·
Aug 14

Trevi Therapeutics is Maintained at Buy by Jones Trading

Dow Jones
·
Aug 14

Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating

MT Newswires Live
·
Aug 14